With no efficacy data available, is the Bharat Biotech vaccine against the coronavirus safe and effective? The Serum Institute of India vaccine will be the main drug, AIIMS Director Dr Randeep Guleria told NDTV, adding that the Bharat Biotech vaccine will only be used as a backup. | NDTV
22:13
With no efficacy data available, is the Bharat Biotech vaccine against the coronavirus safe and effective? The Serum Institute of India vaccine will be the main drug, AIIMS Director Dr Randeep Guleria told NDTV, adding that the Bharat Biotech vaccine will only be used as a backup. | NDTV
已浏览 5万 次2021年1月2日
FacebookNDTV
Coronavirus Vaccine: Bharat Biotech Recruits 23,000 Volunteers For COVAXIN's Phase 3 Clinical Trial
Coronavirus Vaccine: Bharat Biotech Recruits 23,000 Volunteers For COVAXIN's Phase 3 Clinical Trial
2021年1月2日
abplive.com
Bharat Biotech: Get Latest News, Photos and Videos along with latest updates on Bharat Biotech | Hindustan Times
Bharat Biotech: Get Latest News, Photos and Videos along with latest updates on Bharat Biotech | Hindustan Times
2020年4月3日
hindustantimes.com
Bharat Biotech's Covaxin to get WHO nod this week, say sources
Bharat Biotech's Covaxin to get WHO nod this week, say sources
2021年9月13日
INDIA TV
Bharat Biotech’s COVID-19 shot 81% effective, Indian firm’s interim data shows
Bharat Biotech’s COVID-19 shot 81% effective, Indian firm’s interim data shows
2021年3月3日
gmanetwork.com
Covaxin manufacturer Bharat Biotech to carry out clinical trials in US
Covaxin manufacturer Bharat Biotech to carry out clinical trials in US
2021年6月12日
INDIA TV
Bharat Biotech to meet WHO to get EUL approval
2:34
Bharat Biotech to meet WHO to get EUL approval
2021年6月23日
timesnownews.comTamanna Inamdar
Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin
Centre issues Letter of Comfort to Bharat Biotech for 45 lakh doses of Covaxin
2021年1月19日
INDIA TV
COVID-19: Bharat Biotech confirms adverse event during vaccine trial
COVID-19: Bharat Biotech confirms adverse event during vaccine trial
2020年11月21日
india.com
Today, Bharat Biotech International Limited said that it has completed the clinical development for phase III trials and booster doses for the BBV154 (Covaxin) intranasal Covid-19 vaccine. #BharatBiotech #IntranasalCovidVaccine #Covaxin | Oneindia News
1:53
Today, Bharat Biotech International Limited said that it has completed the clinical development for phase III trials and booster doses for the BBV154 (Covaxin) intranasal Covid-19 vaccine. #BharatBiotech #IntranasalCovidVaccine #Covaxin | Oneindia News
已浏览 39 次2022年8月15日
FacebookOneindia News
India’s Bharat Biotech applies for emergency use authorization in PH for its COVID-19 vaccine | ABS-CBN News
India’s Bharat Biotech applies for emergency use authorization in PH for its COVID-19 vaccine | ABS-CBN News
2021年1月21日
abs-cbn.com
Developing 'Covaxin' was an enormous challenge: Bharat Biotech
Developing 'Covaxin' was an enormous challenge: Bharat Biotech
2021年11月19日
INDIA TVIANS
Bharat Biotech terminates agreement with Brazilian partners after graft allegations
Bharat Biotech terminates agreement with Brazilian partners after graft allegations
2021年7月23日
INDIA TVPTI
‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results
2:31
‘Covaxin has 81% efficacy’: Bharat Biotech phase 3 trial results
2021年3月3日
Hindustan TimesMohammad Shuaib
First Covid nasal vaccine by Bharat Biotech gets regulators nod for phase 2, 3 trials
First Covid nasal vaccine by Bharat Biotech gets regulators nod for phase 2, 3 trials
2021年8月13日
INDIA TV
Inactivated vaccines safest with lesser adverse reactions: Bharat Biotech
Inactivated vaccines safest with lesser adverse reactions: Bharat Biotech
2020年12月21日
INDIA TV
Bharat Biotech delivered Covaxin to 30 cities in 1 month; aims WHO approval, US trial
Bharat Biotech delivered Covaxin to 30 cities in 1 month; aims WHO approval, US trial
2021年5月25日
INDIA TV
‘We don’t deserve such backlash’: Bharat Biotech MD
‘We don’t deserve such backlash’: Bharat Biotech MD
2021年1月4日
thenewsminute.comPaul Oommen
Bharat Biotech's Vaccine Cleared By Expert Panel
5:46
Bharat Biotech's Vaccine Cleared By Expert Panel
2021年1月2日
NDTVSonal Mehrotra
‘Bharat Biotech submitting data regularly, very quickly: WHO official on Covaxin approval
‘Bharat Biotech submitting data regularly, very quickly: WHO official on Covaxin approval
2021年10月28日
india.com
Bharat Biotech ramps up Covaxin production, to now manufacture 1 billion doses per year
Bharat Biotech ramps up Covaxin production, to now manufacture 1 billion doses per year
2021年5月20日
INDIA TV
Hyderabad-based Bharat Biotech is working on developing what could be a nasal vaccine to fight the coronavirus pandemic. This vaccine, when ready, will be delivered intranasally. NDTV's Uma Sudhir spoke with Bharat Biotech Joint Managing Director Suchitra Ella. | NDTV
7:04
Hyderabad-based Bharat Biotech is working on developing what could be a nasal vaccine to fight the coronavirus pandemic. This vaccine, when ready, will be delivered intranasally. NDTV's Uma Sudhir spoke with Bharat Biotech Joint Managing Director Suchitra Ella. | NDTV
已浏览 4.6万 次2020年4月28日
FacebookNDTV
Covid-19: Bharat Biotech Completes Phase 3 Trails Of Nasal Vaccine, Data To Be Sent To DCGI Next Month
Covid-19: Bharat Biotech Completes Phase 3 Trails Of Nasal Vaccine, Data To Be Sent To DCGI Next Month
2022年6月18日
abplive.com
Bharat Biotech announces interim analysis results of Phase3 trials Track latest news updates https://bit.ly/2Qo1kkm | The Economic Times
2:28
Bharat Biotech announces interim analysis results of Phase3 trials Track latest news updates https://bit.ly/2Qo1kkm | The Economic Times
已浏览 1.5万 次2021年4月21日
FacebookThe Economic Times
‘iNCOVACC’ to produce three immune responses: Bharat Biotech MD after nasal vaccine launch #BharatBiotech #nasalvaccine #Reels | Asian News International (ANI)
0:27
‘iNCOVACC’ to produce three immune responses: Bharat Biotech MD after nasal vaccine launch #BharatBiotech #nasalvaccine #Reels | Asian News International (ANI)
已浏览 329 次2023年1月26日
FacebookAsian News International (ANI)
India's Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028
India's Bharat Biotech launches cell gene therapy facility, eyes product launch by 2028
9 个月之前
bluewaterhealthyliving.com
A letter by the ICMR asked the company to launch Covaxin by August 15. Bharat Biotech has been asked to accelerate its trails as well and to adhere to the timelines. even DCGI has cleared 'Covaxin' trails. | News18
2:53
A letter by the ICMR asked the company to launch Covaxin by August 15. Bharat Biotech has been asked to accelerate its trails as well and to adhere to the timelines. even DCGI has cleared 'Covaxin' trails. | News18
已浏览 1万 次2020年7月4日
FacebookNews18
Bharat Biotech's intranasal Covid vaccine approved, to be available on CO-WIN from Friday | English News
4:06
Bharat Biotech's intranasal Covid vaccine approved, to be available on CO-WIN from Friday | English News
2022年12月23日
Times NowTimes Now Digital
Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
10:26
Bharat Biotech Releases Covaxin's Phase 3 Trial Data, Claims 77.8% Efficacy
2021年7月3日
NDTV
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
WHO to decide on Bharat Biotech's Covaxin emergency usage in October
2021年9月30日
zeebiz.com
展开